These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 37219053)

  • 1. Retraction statement: Dai, Y., Xie, F. and Chen, Y. (2020), Reduced levels of miR-485-5p in HPV-infected cervical cancer promote cell proliferation and enhance invasion ability. FEBS Open Bio, 10: 1348-1361.
    FEBS Open Bio; 2023 Aug; 13(8):1538. PubMed ID: 37219053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retraction statement: Ding, J., Wang, X., Gao, J. and Song, T. (2021), Silencing of cystatin SN abrogates cancer progression and stem cell properties in papillary thyroid carcinoma. FEBS Open Bio, 11: 2186-2197.
    FEBS Open Bio; 2023 Aug; 13(8):1540. PubMed ID: 37410095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retraction statement: Long noncoding RNA MALAT1 promotes the stemness of esophageal squamous cell carcinoma by enhancing YAP transcriptional activity. FEBS Open Bio, 9: 1392-1402.
    FEBS Open Bio; 2023 Nov; 13(11):2158. PubMed ID: 37792303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retraction statement: Wu, H., He, Y., Chen, H., Liu, Y., Wei, B., Chen, G., Lin, H. and Lin, H. (2019), LncRNA THOR increases osteosarcoma cell stemness and migration by enhancing SOX9 mRNA stability. FEBS Open Bio, 9: 781-790.
    FEBS Open Bio; 2023 Aug; 13(8):1539. PubMed ID: 37219057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retraction statement: Yiwen Xiao, Jingjing Pan, Qian Geng, Ge Wang (2019), LncRNA MALAT1 increases the stemness of gastric cancer cells via enhancing SOX2 mRNA stability. FEBS Open Bio, 9: 1212-1222.
    FEBS Open Bio; 2023 Sep; 13(10):1986. PubMed ID: 37724913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retraction Statement: Circ-TCF4.85 silencing inhibits cancer progression through microRNA-486-5p-targeted inhibition of ABCF2 in hepatocellular carcinoma.
    Mol Oncol; 2023 Jul; 17(7):1453. PubMed ID: 37231579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retraction statement: Shao, L., Zhang, X. and Yao, Q. (2020), The F-box protein FBXO11 restrains hepatocellular carcinoma stemness via promotion of ubiquitin-mediated degradation of Snail. FEBS Open Bio, 10: 1810-1820.
    FEBS Open Bio; 2023 Aug; 13(8):1537. PubMed ID: 37219054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retraction: LBX2-AS1 promotes ovarian cancer progression by facilitating E2F2 gene expression via Mir-455-5p and Mir-491-5p sponging.
    J Cell Mol Med; 2024 Aug; 28(15):e18563. PubMed ID: 39087601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retraction: Kinesin family member 3A stimulates cell proliferation, migration, and invasion of bladder cancer cells in vitro and in vivo.
    FEBS Open Bio; 2024 Mar; 14(3):528. PubMed ID: 38149473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RETRACTION: The long noncoding RNA AK002107 negatively modulates miR-140-5p and targets TGFBR1 to induce epithelial-mesenchymal transition in hepatocellular carcinoma.
    Mol Oncol; 2024 Aug; 18(8):2062. PubMed ID: 38873938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retraction: Wang C, Chen Z, Ge Q, Hu J, Li F, Hu J, Xu H, Ye Z, Li LC (2014) Up-regulation of p21
    FEBS Lett; 2024 Jun; 598(11):1449. PubMed ID: 38747074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retraction statement: Long non-coding RNA PGM5-AS1 promotes epithelial-mesenchymal transition, invasion and metastasis of osteosarcoma cells by impairing miR-140-5p-mediated FBN1 inhibition.
    Mol Oncol; 2023 Aug; 17(8):1692. PubMed ID: 37471281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retraction: The long non-coding RNA-ROR promotes osteosarcoma progression by targeting miR-206.
    J Cell Mol Med; 2024 Mar; 28(6):e18199. PubMed ID: 38439141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retraction: miR-365 secreted from M2 Macrophage-derived extracellular vesicles promotes pancreatic ductal adenocarcinoma progression through the BTG2/FAK/AKT axis.
    J Cell Mol Med; 2024 Feb; 28(4):e18188. PubMed ID: 38396328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retraction Statement: Exosomal miR-1255b-5p targets human telomerase reverse transcriptase in colorectal cancer cells to suppress epithelial-to-mesenchymal transition.
    Mol Oncol; 2023 Jul; 17(7):1454. PubMed ID: 37231586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retraction: CDK4/6 inhibition suppresses tumour growth and enhances the effect of temozolomide in glioma cells.
    J Cell Mol Med; 2024 Mar; 28(6):e18078. PubMed ID: 38073225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retraction: Increased Six1 expression in macrophages promotes hepatocellular carcinoma growth and invasion by regulating MMP-9.
    J Cell Mol Med; 2024 Apr; 28(7):e18249. PubMed ID: 38509734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RETRACTION: Repression of CRNDE Enhances the Anti-Tumour Activity of CD8 + T Cells Against Oral Squamous Cell Carcinoma Through Regulating Mir-545-5p and TIM-3.
    J Cell Mol Med; 2024 Aug; 28(15):e18566. PubMed ID: 39109524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retraction: miR-655 suppresses epithelial-to-mesenchymal transition by targeting Prrx1 in triple-negative breast cancer.
    J Cell Mol Med; 2024 Apr; 28(8):e18314. PubMed ID: 38655709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RETRACTION: miR-664a-3p functions as an oncogene by targeting Hippo pathway in the development of gastric cancer.
    Cell Prolif; 2024 Jul; 57(7):e13681. PubMed ID: 38804819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.